Erratum: Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non–Small-Cell Lung Cancer Risk Factors for Primary Bone Cancer After Childhood Cancer: ...

Investigators conducted a nested case-control study of women aged ≥ 40 years from the general population of Sweden for the years 2009-2019. Analyses assessed menopausal hormone therapy use among 943 ...